Beta Drugs Limited has informed the Exchange about General Updates
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NSE has issued a cautionary email to Beta Drugs Limited for failing to submit the intimation of an audio recording from an Investors/Analysts Meet held on November 7, 2024 within the prescribed 24-hour timeline under SEBI LODR Regulations. The company had submitted the intimation on November 8, 2024, which was considered late by the exchange. NSE has advised the company to be cautious in future, take corrective steps, and ensure timely compliance. The company is required to share this cautionary email with stock exchanges and present it before its Board of Directors.
This is a procedural warning rather than a penalty or enforcement action. It signals minor compliance weakness in disclosure timing but is unlikely to materially affect the stock price. Investors should note that repeated lapses could invite stricter regulatory action in the future.